(19)
(11) EP 1 237 913 A2

(12)

(88) Date of publication A3:
27.12.2001

(43) Date of publication:
11.09.2002 Bulletin 2002/37

(21) Application number: 00985620.4

(22) Date of filing: 18.12.2000
(51) International Patent Classification (IPC)7: C07K 14/195, C07K 14/22, C07K 14/245, C12N 15/10, C12N 15/31, C12N 1/20, C12N 1/36, C12N 1/38, A61K 39/095, A61K 39/108
(86) International application number:
PCT/GB0004/874
(87) International publication number:
WO 0104/4278 (21.06.2001 Gazette 2001/25)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.12.1999 GB 9929923

(71) Applicants:
  • Cantab Pharmaceuticals Research Limited
    Cambridge, Cambridgeshire CB4 0WG (GB)
  • University of Nottingham
    Nottingham, Nottinghamshire NG7 2RD (GB)

(72) Inventors:
  • Baldwin, Thomas John
    Nottingham,Nottinghamshire NG2 5BE (GB)
  • Williams, Paul
    Nottingham,Nottinghamshire NG16 2PU (GB)
  • Swift, Simon
    Leicester,Leicestershire LE12 6RS (GB)
  • McLean, Cornelia Suzanna
    Cambridge,Cambridgeshire CB4 3JW (GB)
  • Holmes, Christopher Lee
    Royston,Hertfordshire SG8 9BL (GB)

(74) Representative: Walton, Seán Malcolm et al
MEWBURN ELLIS,York House,23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) ANTIGEN PREPARATIONS